Patents by Inventor Kelman I. Cohen

Kelman I. Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130310779
    Abstract: High-pressure bleeding wounds (and other bleeding wounds) may be treated by applying direct pressure directly in the bleeding wound, such as by applying a back pressure in a confined space around and in the wound. Certain substances and articles may be inserted into the wound, and the wound may be enclosed with that substance or article (such as a hemostatic substance, which may be polymeric), by swelling on contact with molecules (such as water molecules in the blood) encountered in the wound, generates the desired pressure to stop or at least reduce the bleeding without the detrimental effects of a tourniquet. Clot-inducing substances may be introduced into the wound contemporaneously with direct pressure application directly in the wound. Compressible and non-compressible wounds are treated. Treatment stops bleeding without producing pressure injury or ischemic damage. Medical devices using this technology are provided, including removable, biodegradable, medic-administrable devices.
    Type: Application
    Filed: July 26, 2013
    Publication date: November 21, 2013
    Applicant: Virginia Commonwealth University
    Inventors: Gary Wnek, Marcus E. Carr, JR., Gary Bowlin, Kelman I. Cohen, Kevin R. Ward, Wayne Barbee, Rao Ivatury
  • Patent number: 8497408
    Abstract: High-pressure bleeding wounds (and other bleeding wounds) may be treated by applying direct pressure directly in the bleeding wound, such as by applying a back pressure in a confined space around and in the wound. Certain substances and articles may be inserted into the wound, and the wound may be enclosed with that substance or article (such as a hemostatic substance, which may be polymeric), by swelling on contact with molecules (such as water molecules in the blood) encountered in the wound, generates the desired pressure to stop or at least reduce the bleeding without the detrimental effects of a tourniquet. Clot-inducing substances may be introduced into the wound contemporaneously with direct pressure application directly in the wound. Compressible and non-compressible wounds are treated. Treatment stops bleeding without producing pressure injury or ischemic damage. Medical devices using this technology are provided, including removable, biodegradable, medic-administrable devices.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: July 30, 2013
    Assignee: Virginia Commonwealth University
    Inventors: Gary Wnek, Marcus E. Carr, Jr., Gary Bowlin, Kelman I. Cohen, Kevin R. Ward, Wayne Barbee, Rao Ivatury
  • Publication number: 20120282321
    Abstract: Transition metal (e.g., silver and copper) derivatized phosphorylated polysaccharides (cellulose, starch, gauze) provide antimicrobial and elastase sequestration properties to wound dressings, and the wound dressing have enhanced water sorption and elastase sequestration when used with alginates. Wound dressings with alginates (e.g., silver alginate, crosslinked alginates, etc.) provide enhanced wound fluid absorption as well as elastase sequestration.
    Type: Application
    Filed: July 19, 2012
    Publication date: November 8, 2012
    Inventors: Kelman I. Cohen, Yousef Mohajer
  • Patent number: 8187626
    Abstract: Transition metal (e.g., silver and copper) derivatized phosphorylated polysaccharides (cellulose, starch, gauze) provide antimicrobial and elastase sequestration properties to wound dressings, and the wound dressing have enhanced water sorption and elastase sequestration when used with alginates. Wound dressings with alginates (e.g., silver alginate, crosslinked alginates, etc.) provide enhanced wound fluid absorption as well as elastase sequestration.
    Type: Grant
    Filed: May 13, 2010
    Date of Patent: May 29, 2012
    Assignee: Tissue Technologies, LLC
    Inventors: Kelman I. Cohen, Yousef Mohajer
  • Publication number: 20110123597
    Abstract: Transition metal (e.g., silver and copper) derivatized phosphorylated polysaccharides (cellulose, starch, gauze) provide antimicrobial and elastase sequestration properties to wound dressings, and the wound dressing have enhanced water sorption and elastase sequestration when used with alginates. Wound dressings with alginates (e.g., silver alginate, crosslinked alginates, etc.) provide enhanced wound fluid absorption as well as elastase sequestration.
    Type: Application
    Filed: February 2, 2011
    Publication date: May 26, 2011
    Inventors: Kelman I. COHEN, Yousef MOHAJER
  • Publication number: 20100221311
    Abstract: Transition metal (e.g., silver and copper) derivatized phosphorylated polysaccharides (cellulose, starch, gauze) provide antimicrobial and elastase sequestration properties to wound dressings, and the wound dressing have enhanced water sorption and elastase sequestration when used with alginates. Wound dressings with alginates (e.g., silver alginate, crosslinked alginates, etc.) provide enhanced wound fluid absorption as well as elastase sequestration.
    Type: Application
    Filed: May 13, 2010
    Publication date: September 2, 2010
    Inventors: Kelman I. Cohen, Yousef Mohajer
  • Publication number: 20100221312
    Abstract: Transition metal (e.g., silver and copper) derivatized phosphorylated polysaccharides (cellulose, starch, gauze) provide antimicrobial and elastase sequestration properties to wound dressings, and the wound dressing have enhanced water sorption and elastase sequestration when used with alginates. Wound dressings with alginates (e.g., silver alginate, crosslinked alginates, etc.) provide enhanced wound fluid absorption as well as elastase sequestration.
    Type: Application
    Filed: May 13, 2010
    Publication date: September 2, 2010
    Inventors: Kelman I. Cohen, Yousef Mohajer
  • Publication number: 20040013715
    Abstract: High-pressure bleeding wounds (and other bleeding wounds) may be treated by applying direct pressure directly in the bleeding wound, such as by applying a back pressure in a confined space around and in the wound. Certain substances and articles may be inserted into the wound, and the wound may be enclosed with that substance or article (such as a hemostatic substance, which may be polymeric), by swelling on contact with molecules (such as water molecules in the blood) encountered in the wound, generates the desired pressure to stop or at least reduce the bleeding without the detrimental effects of a tourniquet Clot-inducing substances may be introduced into the wound contemporaneously with direct pressure application directly in the wound. Compressible and non-compressible wounds are treated. Treatment stops bleeding without producing pressure injury or ischemic damage. Medical devices using this technology are provided, including removable, biodegradable, medic-administrable devices.
    Type: Application
    Filed: August 13, 2003
    Publication date: January 22, 2004
    Inventors: Gary Wnek, Marcus E Carr, Gary Bowlin, Kelman I Cohen, Kevin R Ward, Wayne Barbee, Rao Ivatury
  • Publication number: 20030206944
    Abstract: The invention provides wound dressings and methods of their use, especially for the treatment of chronic, non-healing wounds. The wound dressings are composed of a support matrix, such as cotton cellulose, and an active agent associated with the support matrix. The active agent may be a protease inhibitor or a protease sequestrant, in particular an inhibitor or sequestrant of a neutrophil-derived cationic protease such as elastase.
    Type: Application
    Filed: May 29, 2003
    Publication date: November 6, 2003
    Inventors: Kelman I. Cohen, Robert F. Diegelmann, Dorne Yager, Judson Vincent Edwards
  • Patent number: 6599523
    Abstract: The invention provides wound dressings and methods of their use, especially for the treatment of chronic, non-healing wounds. The wound dressings are composed of a support matrix, such as cotton cellulose, and an active agent associated with the support matrix. The active agent may be a protease inhibitor or a protease sequestrant, in particular an inhibitor or sequestrant of a neutrophil-derived cationic protease such as elastase.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: July 29, 2003
    Assignees: Virginia Commonwealth University, The United States of America as represented by the Department of Agriculture
    Inventors: Kelman I. Cohen, Robert F. Diegelmann, Dorne Yager, Judson Vincent Edwards
  • Publication number: 20020012693
    Abstract: The invention provides wound dressings and methods of their use, especially for the treatment of chronic, non-healing wounds. The wound dressings are composed of a support matrix, such as cotton cellulose, and an active agent associated with the support matrix. The active agent may be a protease inhibitor or a protease sequestrant, in particular an inhibitor or sequestrant of a neutrophil-derived cationic protease such as elastase.
    Type: Application
    Filed: February 28, 2001
    Publication date: January 31, 2002
    Inventors: Kelman I. Cohen, Robert F. Diegelmann, Dorne Yager, Judson Vincent Edwards